Abstract
Regulation of the rapid compensatory growth seen in the remaining adrenal gland of rats following unilateral adrenalectomy is poorly understood. The role of adrenocorticotropic hormone (ACTH) is obscure1,2 as immunoneutralization of circulating ACTH does not affect the observed compensatory growth or hyperplasia1. This finding, together with the fact that mechanical manipulation of one adrenal without extirpation is followed by growth only in the contralateral gland3, has led to the concept of neural regulation of compensatory adrenal growth via a loop from one adrenal through the hypothalamus and back to the contralateral gland which is independent of ACTH secretion3. We recently showed that peptides from the N terminal of ACTH precursor proopiocortin (POC), not containing the γ-melanocyte-stimulating hormone (γ-MSH) sequence, can stimulate adrenal mitogenesis and proposed that normal long-term adrenal growth and proliferation involves post-secretional proteolytic cleavage of pro-γ-MSH [or N-POC(1–74)] to generate the mitogenic factor N-POC(1–48/49) and a C-terminal fragment N-POC(50–74), or rat γ3-MSH4. We have now investigated this hypothesis further in rats by selectively quenching different regions of circulating POC peptides with specific antisera and observing the effect on the increases in weight, RNA and DNA normally seen in the remaining gland following unilateral adrenalectomy1–3. Our results, reported here, suggest that neurally mediated proteolytic cleavage of the circulating inactive mitogenic precursor pro-γ-MSH at the adrenal gland is the major mechanism of control of compensatory growth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Long, J. A. & Ramachandran, J. J. Endocr. 102, 371–378 (1978).
Dallman, M. F., Engeland, W. C., Holzwarth, M. A. & Scholtz, P. M. Endocrinology 107, 1397–1404 (1980).
Dallman, M. F., Engeland, W. C. & Shinsako, J. Am. J. Physiol. 231, 408–414 (1976).
Estivariz, F., Iturriza, F., McLean, C., Hope, J. & Lowry, P. J. Nature 297, 419–422 (1982).
Al-Dujaili, E. A. S., Williams, B. C., Edwards, C. R. W., Salacinski, P. & Lowry, P. J. Biochem. J. 204, 301–305 (1982).
Al-Dujaili, E. A. S., Hope, J., Estivariz, F., Lowry, P. J. & Edwards, C. R. W. Nature 291, 156–159 (1981).
Pedersen, R. C., Brownie, A. C. & Ling, N. Science 208, 1044–1045 (1980).
Eipper, B. A. & Mains, R. E. J. submolec. Struct. 8, 249–262 (1978).
Hope, J. & Lowry, P. J. Frontiers Horm. Res. 8, 44–61 (1981).
Hope, J., Ratter, S. J., Estivariz, F., McLoughlin, L. & Lowry, P. J. Clin Endocr. 15, 221–227 (1981).
Estivariz, F., Gillies, G. & Lowry, P. J. Pharmac. Ther. 13, 61–67 (1981).
Eipper, B. A. & Mains, R. E. Endocr. Rev. 1, 1–27 (1980).
Jackson, S. & Lowry, P. J. J. Endocr. 86, 205–219 (1980).
Mains, R. E. & Eipper, B. A. J. biol. Chem. 251, 7885–7894 (1979).
Crine, P., Seidah, N. G., Routhier, R., Gossard, F. & Chretien, M. Eur. J. Biochem. 110, 387–396 (1980).
Mains, R. E. & Eipper, B. A. Ann. N. Y. Acad. Sci. 343, 94–110 (1980).
Penny, R. J. & Thody, A. J. Neuroendocrinology 25, 193–203 (1978).
Tilders, F. J. H. & Smelik, P. G. Neuroendocrinology 25, 275–290 (1978).
Engeland, W. C. & Dallman, M. F. Endocrinology 99, 1659–1662 (1976).
Greer, M. A., Allen, C. F., Panton, P. & Allen, P. G. Endocrinology 96, 718–724 (1975).
Scott, A. P. & Lowry, P. J. Biochem. J. 139, 593–602 (1974).
McLean, C., Hope, J., Salacinski, P., Estivariz, F. & Lowry, P. J. Biosci. Rep. 1, 843–849 (1981).
Drouin, J. & Goodman, H. M. Nature 288, 610–618 (1980).
Estivariz, F., Hope, J., McLean, C & Lowry, P. J. Biochem. J. 191, 125–132 (1980).
Schneider, W. C. Biol. Chem. 161, 293–303 (1945).
Mejbaum, W. Physiol. Chem. 258, 117–120 (1939).
Giles, K. W. & Myers, A. Nature 206, 93 (1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lowry, P., Silas, L., McLean, C. et al. Pro-γ-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 306, 70–73 (1983). https://doi.org/10.1038/306070a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/306070a0
This article is cited by
-
Comparative effect of FGF2, synthetic peptides 1-28 N-POMC and ACTH on proliferation in rat adrenal cell primary cultures
Cell and Tissue Research (2011)
-
Synthetic modified N-POMC1–28 controls in vivo proliferation and blocks apoptosis in rat adrenal cortex
Cell and Tissue Research (2010)
-
The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience
Journal of Endocrinological Investigation (2007)
-
Effects of TRH and TRH-like peptide pGLU-HIS-GLY-NH2 on adrenocortical cell proliferation in rats
Endocrine (1996)
-
The “4A” syndrome: Adrenocortical insufficiency associated with achalasia, alacrima, autonomic and other neurological abnormalities
European Journal of Pediatrics (1995)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
